Merck B.V.
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- ULCOGANT oral suspension 1 g/5 ml
- ULCOGANT powder for oral solution 1 g
- ULCOGANT tablet 1 g
- A10 - Antidiabéticos
- GLUCOPHAGE film-coated tablet 1 000 mg
- GLUCOPHAGE film-coated tablet 500 mg
- GLUCOPHAGE film-coated tablet 850 mg
- GLUCOVANCE film-coated tablet 500 mg+2.5 mg
- GLUCOVANCE film-coated tablet 500 mg+5 mg
- A11 - Vitaminas
- NEUROBION solution for injection 100 mg/3 ml+100 mg/3 ml+1 mg/3 ml
- C07 - Betabloqueantes
- EMCOR film-coated tablet 10 mg
- EMCOR film-coated tablet 2.5 mg
- EMCOR film-coated tablet 5 mg
- EMCOR film-coated tablet 7.5 mg
- EMCORETIC film-coated tablet 10 mg+25 mg
- EMCORETIC film-coated tablet 5 mg+12.5 mg
- G03 - Hormonas sexuales y moduladores del sistema genital
- FEM7 SEQUI transdermal patch 50 µg/24 h - 50 µg/24 h+10 µg/24 h
- FEM7 transdermal patch 50 µg/24 h
- NAEMIS tablet 1.5 mg - 1.5 mg+3.75 mg
- H03 - Terapia tiroidea
- EUTHYROX tablet 100 µg
- EUTHYROX tablet 125 µg
- EUTHYROX tablet 150 µg
- EUTHYROX tablet 175 µg
- EUTHYROX tablet 200 µg
- EUTHYROX tablet 25 µg
- EUTHYROX tablet 50 µg
- EUTHYROX tablet 75 µg
- LEVOTHYROX tablet 150 µg
- LEVOTHYROX tablet 175 µg
- LEVOTHYROX tablet 200 µg
- LEVOTHYROX tablet 25 µg
- LEVOTHYROX tablet 50 µg
- LEVOTHYROX tablet 75 µg
- M02 - Productos tópicos para dolor articular y muscular
- OSMOGEL gel 1%+25%
- N07 - Otros fármacos activos sobre el sistema nervioso
- CAMPRAL gastro-resistant tablet 333 mg
- R01 - Preparaciones nasales
- NASIVIN nasal drops, solution 0.025%
- NASIVIN nasal drops, solution 0.05%
- NASIVIN nasal spray, solution 0.05%
- V03 - Todos los demás preparados terapéuticos
- TOXOGONIN solution for injection 0.25 g/ml